Previous 10 | Next 10 |
2024-04-24 17:14:01 ET A California-based %Biotech company is finding pretty serious success on Wednesday a day after the company filed a registration statement covering the potential sale of up to $50 million mixed shelf offering, which covered common shares, preferred shares, debt sec...
2024-04-01 08:31:15 ET More on Pre-market losers & stocks. MicroStrategy Is A $1 Box Of Bitcoin Trading For $1.91 Biora Therapeutics, Inc. (BIOR) Q4 2023 Earnings Call Transcript MicroStrategy: A Bad Deal For Investors MicroStrategy among most squeezable ...
A look at the top 10 most actives in the United States Nikola Corporation (NKLA) rose 11.7% to $0.9091 on volume of 189,265,043 shares iBio Inc. (IBIO) rose 192.2% to $3.36 on volume of 167,159,370 shares Verb Technology Company Inc. (VERB) rose 0.4% to $0.281 on volume of 126,638,529 sha...
2024-03-27 14:46:54 ET A California-based %Biotech company stirred things up on Wednesday after it was announced the publication of preclinical data on its lead clinical compound, LB-100. Traders couldn’t get their hands on shares of %LixteBiotechnology (NASDAQ: $LIXT), p...
2024-03-27 14:43:15 ET More on Lixte Biotechnology Holdings, Inc. Financial information for Lixte Biotechnology Holdings, Inc. Read the full article on Seeking Alpha For further details see: Lixte stock soars on preclinical data for lead drug LB-100
Lixte Biotechnology Holdings, Inc. (NASDAQ: LIXT) is one today's most active stocks by volume. So far today, approximately 22.95M shares of Lixte Biotechnology Holdings, Inc. have been exchanged, as compared to an average 30-day volume of 86,145 shares. Lixte Biotechnology Holdings, Inc. opera...
2024-03-27 10:00:45 ET More on Health Care Select Sector SPDR XLV: Fundamentals Don't Support Overweighting Health Care XLV: Low-Cost Exposure To A Defensive Sector, While Achieving Strong Performance Healthcare In 2024: Navigating The Biopharma Bull Run John...
A look at the top 10 most actives in the United States Verb Technology Company Inc. (VERB) rose 34.1% to $0.3754 on volume of 55,110,141 shares Gamida Cell Ltd. (GMDA) fell 82.7% to $0.0594 on volume of 50,587,982 shares iBio Inc. (IBIO) rose 111.3% to $2.43 on volume of 40,863,066 shares...
LB-100 IS SYNERGISTIC WITH WEE1 INHIBITION IN KILLING CANCER CELLS; FINDING OPENS NEW TREATMENT STRATEGY IN ADDITION TO THREE CURRENT LIXTE CLINICAL TRIALS PASADENA, CA, March 27, 2024 (GLOBE NEWSWIRE) -- LIXTE Biotechnology Holdings, Inc . (“LIXTE” or the “Company&...
-- Three Clinical Trials Currently Underway for Treating Ovarian, Lung and Sarcoma Cancers -- PASADENA, Calif., March 21, 2024 (GLOBE NEWSWIRE) -- LIXTE Biotechnology Holdings, Inc . (“LIXTE” or the “Company”) (Nasdaq: LIXT and LIXTW), a clinical-stage ...
News, Short Squeeze, Breakout and More Instantly...
Lixte Biotechnology Holdings Inc. Company Name:
LIXT Stock Symbol:
OTCMKTS Market:
Clinical trial to test recent findings that show LIXTE’s lead clinical compound, LB-100, increases recognition of colon cancer cells by the immune system PASADENA, CA, June 14, 2024 (GLOBE NEWSWIRE) -- LIXTE Biotechnology Holdings, Inc . (“LIXTE” or the ...
Clinical trial to test recent findings that show LIXTE’s lead clinical compound, LB-100, increases recognition of colon cancer cells by the immune system PASADENA, CA, June 14, 2024 (GLOBE NEWSWIRE) -- LIXTE Biotechnology Holdings, Inc . (“LIXTE” or the ȁ...
LB-100 Generates Neo-Antigens in Cancer Cells that are Presented to the Immune System by Disrupting the Process of RNA Splicing PASADENA, CA, June 06, 2024 (GLOBE NEWSWIRE) -- LIXTE Biotechnology Holdings, Inc . (“LIXTE” or the “Company”) ( ...